1620575-08-7

Basic information

• Product Name: 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-(trifluoromethoxy)pyridin-2-amine
• Synonyms: 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-(trifluoromethoxy)pyridin-2-amine
• CAS NO: 1620575-08-7
• Molecular Weight: 304.077
• Mol File: 1620575-08-7.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-(trifluoromethoxy)pyridin-2-amine(CAS DataBase Reference)
• NIST Chemistry Reference: 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-(trifluoromethoxy)pyridin-2-amine(1620575-08-7)
• EPA Substance Registry System: 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-(trifluoromethoxy)pyridin-2-amine(1620575-08-7)

Safety Data

• Hazardous Substances Data: 1620575-08-7(Hazardous Substances Data)

Usage

Structure

Contains a pyridine ring with an amine group attached, as well as a boron-containing group and a trifluoromethoxy group

Chemical properties

Likely to have specific chemical properties that can be utilized in various fields such as pharmaceuticals, materials, and organic synthesis

Potential applications

Can be used in organic reactions and as a building block for more complex molecules

Further study

Required to determine the full potential and possible uses of this compound

Upstream product

• 15128-82-2 3-hydroxy-2-nitropyridine 
• 1361852-35-8 5-bromo-3-(trifluoromethoxy)pyridin-2-amine 
• 73183-34-3 bis(pinacol)diborane 
• 1206981-49-8 2-amino-3-(trifluoromethoxy)pyridine 
• 1361824-81-8 2-nitro-3-(trifluoromethoxy)pyridine 
• 1620575-07-6 3-(bromodifluoromethoxy)-2-nitropyridine 

Relevant articles and documents

PYRAZOLE DERIVATIVES AND USES THEREOF AS INHIBITORS OF DLK

The present invention provides for compounds of formula 0 and various embodiments thereof, and compositions comprising compounds of formula 0 and various embodiments thereof. In compounds of formula 0, the groups R1A, R1B, R1C, R1D, R2, R3, R4, R5 and R6 have the meaning as described herein. The present invention also provides for methods of using compounds of formula 0 and compositions comprising compounds of formula 0 as DLK inhibitors and for treating neurodegeneration diseases and disorders.

3-SUBSTITUTED PYRAZOLES AND USE AS DLK INHIBITORS

The present invention provides for compounds of Formula (I) and various embodiments thereof, and compositions comprising compounds of Formula (I) and various embodiments thereof. (I) In compounds of Formula I, the groups R1, R2, R3, R4, R5, R6 and R7 have the meaning as described herein. The present invention also provides for methods of using compounds of Formula I and compositions comprising compounds of Formula (I) as DLK inhibitors and for treating neurodegeneration diseases and disorders.